Moreover, miR-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer, suggesting that plasma miR-155 may serve as a non-invasive biomarker for detection of early-stage breast cancer [18]. Here, FOXP3 is linked to breast cancer.